Cresco Labs Stock Today
CRLBF Stock | USD 1.28 0.13 11.30% |
Performance0 of 100
| Odds Of DistressOver 68
|
Cresco Labs is trading at 1.28 as of the 8th of November 2024. This is a 11.30 percent increase since the beginning of the trading day. The stock's lowest day price was 1.1. Cresco Labs has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Cresco Labs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of November 2023 and ending today, the 8th of November 2024. Click here to learn more.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company was founded in 2013 and is headquartered in Chicago, Illinois. Cresco Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 280.99 M outstanding shares. More on Cresco Labs
Moving against Cresco OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cresco OTC Stock Highlights
CEO, Director | Charles Bachtell |
Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Cresco Labs [CRLBF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 545.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cresco Labs's market, we take the total number of its shares issued and multiply it by Cresco Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cresco Labs classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 280.99 M outstanding shares.
Cresco Labs has accumulated about 130.04 M in cash with 14.49 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43.
Check Cresco Labs Probability Of Bankruptcy
Ownership AllocationCresco Labs holds a total of 280.99 Million outstanding shares. Cresco Labs retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cresco Ownership Details
Cresco Labs Risk Profiles
Mean Deviation | 3.15 | |||
Standard Deviation | 5.12 | |||
Variance | 26.19 | |||
Risk Adjusted Performance | (0.03) |
Cresco Stock Against Markets
Picking the right benchmark for Cresco Labs otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cresco Labs otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cresco Labs is critical whether you are bullish or bearish towards Cresco Labs at a given time. Please also check how Cresco Labs' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cresco Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Cresco Labs Corporate Management
Elected by the shareholders, the Cresco Labs' board of directors comprises two types of representatives: Cresco Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cresco. The board's role is to monitor Cresco Labs' management team and ensure that shareholders' interests are well served. Cresco Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cresco Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Ty Gent | Chief Officer | Profile | |
John Schetz | G Counsel | Profile | |
Brenna CPA | Treasury Accounting | Profile | |
Zach Marburger | Interim Officer | Profile |
Other Information on Investing in Cresco OTC Stock
Cresco Labs financial ratios help investors to determine whether Cresco OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cresco with respect to the benefits of owning Cresco Labs security.